Related Experiment Video

Updated: Sep 25, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Selective estrogen receptor modulators: Women's panacea for the next millennium?

C P Spencer1, E P Morris, J M Rymer

  • 1Department of Obstetrics and Gynaecology, St Thomas' Hospital, London, United Kingdom.

American Journal of Obstetrics and Gynecology
|March 17, 1999
PubMed

Insights

Selective estrogen receptor modulators show promise for postmenopausal women. These agents may improve bone density and lipid profiles while potentially reducing cancer risks, though long-term studies are necessary.

Area of Science:

  • Pharmacology
  • Women's Health
  • Endocrinology

Background:

  • Postmenopausal women face risks of osteoporosis, cardiovascular disease, and certain cancers.
  • Estrogen plays a role in bone health, lipid metabolism, and reproductive tissues.

Purpose of the Study:

  • To review the potential of selective estrogen receptor modulators (SERMs) for postmenopausal women's health.
  • To outline the mechanisms of action for SERMs.

Main Methods:

  • Literature review of experimental and clinical data on SERMs.
  • Analysis of SERM effects on bone, lipids, endometrium, and breast tissue.

Main Results:

  • SERMs exhibit tissue-specific agonist/antagonist activity.
  • Raloxifene shows short-term bone preservation and improved lipid profiles.
  • Potential benefits include reduced fracture and cardiovascular risk, and lower incidence of breast/endometrial neoplasms.

Conclusions:

  • SERMs offer theoretical benefits for postmenopausal health.
  • Further long-term studies are required to confirm cancer risk reduction with SERMs like raloxifene.

More Related Videos

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory14:13

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory

Published on: January 1, 2018

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Related Concept Videos

Hormonal Regulation02:03

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.The ProcessStarting in the stomach, when proteins are detected by sensory neurons of the enteric nervous system, the pyloric gland is stimulated to release gastrin. In turn, this hormone induces the release of histamine. Combined, they...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...